Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohsin Shah

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
JPMA. the Journal of the Pakistan Medical Association|February 29, 2012
Smouldering systemic mastocytosis: a rare disorder with a difficult diagnosisMohsin Shah
JPMA. the Journal of the Pakistan Medical Association|July 29, 2008
Bronchial thermoplasty: a novel approach to asthma treatmentMohsin Shah
Clinical Medicine Insights. Case Reports|December 21, 2020
SARS-CoV-2 and Anti-Cardiolipin AntibodiesMazen Jizzini, Mohsin Shah, Kehua Zhou
Current Protein & Peptide Science|January 20, 2024
Neurokinin B Administration Induces Dose Dependent Proliferation of Seminal Vesicles in Adult RatsMuhammad Haris Ramzan, Mohsin Shah, Faiqah Ramzan
BMC Medical Education|January 19, 2010
Perceived stress, sources and severity of stress among medical undergraduates in a Pakistani medical schoolMohsin Shah, Shahid Hasan, Samina Malik, et al.
Plos One|July 30, 2016
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case ReportsNoha Abdel-Wahab, Mohsin Shah, Maria E Suarez-Almazor
The Journal of Emergency Medicine|July 4, 2019
Extramedullary Plasmacytoma Involving the Trachea: A Case Report and Literature ReviewMazen Nizar Jizzini, Mohsin Shah, Sai-Ching Jim Yeung
Journal of Neurosurgery. Pediatrics|March 21, 2008
Adverse facial edema associated with off-label use of recombinant human bone morphogenetic protein-2 in cranial reconstruction for craniosynostosis. Case reportM Mohsin Shah, Matthew D Smyth, Albert S Woo
Clinical Lung Cancer|March 19, 2023
Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer With a PD-L1 Expression ≥50% or ≥90Mohsin Shah, Ronac Mamtani, Melina E Marmarelis, et al.
Clinical Lung Cancer|August 9, 2022
Association Between Survival and Very High Versus High PD-L1 Expression in Patients Receiving Pembrolizumab as First-line Treatment for Advanced Non-Small Cell Lung CancerMohsin Shah, Melina E Marmarelis, Ronac Mamtani, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
JPMA. the Journal of the Pakistan Medical Association|February 29, 2012
Smouldering systemic mastocytosis: a rare disorder with a difficult diagnosisMohsin Shah
JPMA. the Journal of the Pakistan Medical Association|July 29, 2008
Bronchial thermoplasty: a novel approach to asthma treatmentMohsin Shah
Clinical Medicine Insights. Case Reports|December 21, 2020
SARS-CoV-2 and Anti-Cardiolipin AntibodiesMazen Jizzini, Mohsin Shah, Kehua Zhou
Current Protein & Peptide Science|January 20, 2024
Neurokinin B Administration Induces Dose Dependent Proliferation of Seminal Vesicles in Adult RatsMuhammad Haris Ramzan, Mohsin Shah, Faiqah Ramzan
BMC Medical Education|January 19, 2010
Perceived stress, sources and severity of stress among medical undergraduates in a Pakistani medical schoolMohsin Shah, Shahid Hasan, Samina Malik, et al.
Plos One|July 30, 2016
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case ReportsNoha Abdel-Wahab, Mohsin Shah, Maria E Suarez-Almazor
The Journal of Emergency Medicine|July 4, 2019
Extramedullary Plasmacytoma Involving the Trachea: A Case Report and Literature ReviewMazen Nizar Jizzini, Mohsin Shah, Sai-Ching Jim Yeung
Journal of Neurosurgery. Pediatrics|March 21, 2008
Adverse facial edema associated with off-label use of recombinant human bone morphogenetic protein-2 in cranial reconstruction for craniosynostosis. Case reportM Mohsin Shah, Matthew D Smyth, Albert S Woo
Clinical Lung Cancer|March 19, 2023
Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer With a PD-L1 Expression ≥50% or ≥90Mohsin Shah, Ronac Mamtani, Melina E Marmarelis, et al.
Clinical Lung Cancer|August 9, 2022
Association Between Survival and Very High Versus High PD-L1 Expression in Patients Receiving Pembrolizumab as First-line Treatment for Advanced Non-Small Cell Lung CancerMohsin Shah, Melina E Marmarelis, Ronac Mamtani, et al.
Pageof 8